One-pot synthesis of monodisperse dual-functionalized polyethylene glycols through macrocyclic sulfates

被引:7
作者
Lv, Xiaoyan [1 ]
Zheng, Xing [2 ]
Yang, Zhigang [1 ]
Jiang, Zhong-Xing [1 ]
机构
[1] Wuhan Univ, Sch Pharmaceut Sci, Hubei Prov Engn & Technol Res Ctr Fluorinated Pha, Wuhan 430071, Hubei, Peoples R China
[2] Univ South China, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
OLIGO(ETHYLENE GLYCOL); POLY(ETHYLENE GLYCOL)S; ASYMMETRIC-SYNTHESIS; DRUG-DELIVERY; PEGYLATION; PEG; DESIGN; CHROMATOGRAPHY; THERAPEUTICS; ENANTIOMERS;
D O I
10.1039/c8ob02392a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Dual-functionalization of monodisperse oligoethylene glycols, especially hetero-functionalization, provides a series of highly valuable intermediates for life and materials sciences. However, the existing methods for the preparation of these compounds suffer excessive protecting and activating group manipulation as well as tedious purification. Here, a one-pot dual-substitution strategy with macrocyclic sulfates of polyethylene glycols as the key intermediates was developed for the convenient and scalable preparation of a series of homo-functionalized and hetero-functionalized oligoethylene glycols in just 1 step. A high synthetic efficacy was achieved by avoiding the protecting and activating group manipulation and the intermediate purification.
引用
收藏
页码:8537 / 8545
页数:9
相关论文
共 40 条
  • [1] Synthesis of Oligo(ethylene glycol) toward 44-mer
    Ahmed, Saleh A.
    Tanaka, Mutsuo
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (26) : 9884 - 9886
  • [2] Design and Synthesis of Highly Potent and Plasma-Stable Dimeric Inhibitors of the PSD-95-NMDA Receptor Interaction
    Bach, Anders
    Chi, Celestine N.
    Pang, Gar F.
    Olsen, Lars
    Kristensen, Anders S.
    Jemth, Per
    Stromgaard, Kristian
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (51) : 9685 - 9689
  • [3] Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: Synthesis, characterization and cellular uptake
    Berna, M
    Dalzoppo, D
    Pasut, G
    Manunta, M
    Izzo, L
    Jones, AT
    Duncan, R
    Veronese, FM
    [J]. BIOMACROMOLECULES, 2006, 7 (01) : 146 - 153
  • [4] In vivo drug tracking with 19F MRI at therapeutic dose
    Bo, Shaowei
    Yuan, Yaping
    Chen, Yongping
    Yang, Zhigang
    Chen, Shizhen
    Zhou, Xin
    Jiang, Zhong-Xing
    [J]. CHEMICAL COMMUNICATIONS, 2018, 54 (31) : 3875 - 3878
  • [5] Design and Synthesis of Fluorinated Amphiphile as 19F MRI/Fluorescence Dual-Imaging Agent by Tuning the Self-Assembly
    Bo, Shaowei
    Song, Cong
    Li, Yu
    Yu, Weijiang
    Chen, Shizhen
    Zhou, Xin
    Yang, Zhigang
    Zheng, Xing
    Jiang, Zhong-Xing
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2015, 80 (12) : 6360 - 6366
  • [6] Therapeutic antibody fragments with prolonged in vivo half-lives
    Chapman, AP
    Antoniw, P
    Spitali, M
    West, S
    Stephens, S
    King, DJ
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (08) : 780 - 783
  • [7] PEG-proteins: Reaction engineering and separation issues
    Fee, CJ
    Van Alstine, JA
    [J]. CHEMICAL ENGINEERING SCIENCE, 2006, 61 (03) : 924 - 939
  • [8] The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics
    Fishburn, C. Simone
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (10) : 4167 - 4183
  • [9] High-Purity Discrete PEG-Oligomer Crystals Allow Structural Insight
    French, Alister C.
    Thompson, Amber L.
    Davis, Benjamin G.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (07) : 1248 - 1252
  • [10] Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242